Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery
Sponsor : National Institutes of Health
Deal Size : $3.0 million
Deal Type : Funding
Versatope Receives Grants to Support Malaria Vaccine Development
Details : The Versatope will use the grant to develop a bi-specific malaria vaccine using a target that blocks both the initial malaria infection and transmission.
Brand Name : Undisclosed
Molecule Type : Vaccine
Upfront Cash : Undisclosed
July 29, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery
Sponsor : National Institutes of Health
Deal Size : $3.0 million
Deal Type : Funding
LOOKING FOR A SUPPLIER?